Hovnanian Enterprises, Inc. is a U.S. homebuilder, not an ETF. Its analyst coverage is notably thin and currently tilted negative. The most recent verifiable target is a $74 "Market Underperform" initiation from Citizens (James McCanless, April 9, 2026). Aggregators such as MarketBeat and Investing.com list an average twelve-month target near $74, with a consensus recommendation in the "Reduce" to "Sell" range. A prior Wedbush hold rating with a $120 target dates to mid-2025 and is effectively stale in the context of more recent research.
Because these current targets sit below the $104.92 market price, they cannot form the basis of a meaningful upside question. For that reason this article uses a fallback objective of $130, which reflects public valuation and technical discussion — specifically a valuation-based estimate near $134 (GuruFocus GF Value) and a recovery toward the upper portion of the 52-week trading range — rather than any analyst consensus.
With shares at $104.92, a move to $130 implies about 24% upside. Hovnanian trades at roughly 0.9 times book value (book value per share near $114.68) and a trailing P/E (price-to-earnings ratio) well above 90, reflecting earnings that have compressed sharply — net income fell roughly 89% year over year to about $6.75 million on roughly $2.8 billion in trailing revenue. Quarterly revenue declined about 12% year over year. The stock sits below both its 50-day moving average (about $112) and 200-day moving average (about $118), meaning a sustained recovery would require the shares to first reclaim those trend markers before testing higher levels toward the $148.48 52-week high.
HOV's 52-week range spans $90.17 to $148.48. The stock currently sits near the lower-middle of that band. The 50-day moving average near $112 and the 200-day moving average near $118 represent intermediate resistance zones that the shares would need to clear before the $130 objective becomes realistic; the $148.48 prior high is the most durable resistance above. On the downside, the $90 area marks the recent support floor. This structure frames $130 as a recovery target requiring a decisive reclaiming of both moving averages, not a near-term inflection point.
Analyst targets are typically set over a roughly twelve-month horizon, though with coverage this thin there is little basis to specify a precise timeframe. Key items to watch include the next quarterly earnings report (estimated for early December 2026) and any update to revenue guidance, which management has recently placed in the $625–$750 million per-quarter range; buyback activity; mortgage-rate and Federal Reserve policy developments; and any news flow on the reported homebuilder antitrust review. Changes in revenue trajectory and net income will likely matter more to the stock's direction than any single valuation multiple.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than replacing your own research, the tool is designed to help traders discover new opportunities, keep an eye on existing positions, and spot shifting trends more efficiently. If you want a systematic way to track evolving signals across the market, exploring the AI Daily Buy/Sell Signals is a practical next step.
Whether Hovnanian Enterprises can reach $130 depends on a recovery that its current analyst coverage does not yet support — the few active targets sit near $74, below the market price. The $130 figure is a fallback objective from public valuation and technical discussion, implying a substantial 24% gain that would require the stock to reclaim its moving averages and re-establish earnings momentum. Supportive factors include a discount to book value and an active buyback, while declining revenues, compressed profits, high leverage, and mortgage-rate and regulatory headwinds are the principal obstacles. Investors should monitor earnings, guidance, and interest-rate and antitrust developments rather than treat $130 as a forecast or guarantee.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, HOV has been closely correlated with LGIH. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if HOV jumps, then LGIH could also see price increases.
| Ticker / NAME | Correlation To HOV | 1D Price Change % | ||
|---|---|---|---|---|
| HOV | 100% | +2.30% | ||
| LGIH - HOV | 77% Closely correlated | +1.57% | ||
| MTH - HOV | 73% Closely correlated | +0.06% | ||
| GRBK - HOV | 72% Closely correlated | +1.69% | ||
| MHO - HOV | 72% Closely correlated | +0.46% | ||
| DHI - HOV | 72% Closely correlated | +0.61% | ||
More | ||||